The beefy armed guard at the door of the Church of Entheogenic Plants chuckled at the sight of me, and I guessed what he might be thinking: Whats that 60-something lady doing here?
It wouldnt have been unreasonable to wonderand not just because everyone else waiting to pass through the metal detector that day last winter was roughly 40 years younger than I. Vice News has called the Oakland, CA, church, also known as Zide Door, Americas most prominent magic mushroom club, implying that its religious decor is a ruse to evade state and federal laws against selling psychedelic drugs. In accepting contributions for strains of shrooms with names like Blue Meanies and Penis Envy, Zide Door claims the same exemption that lets the Navajo legally ingest peyote, a traditional sacrament.
Ruse or not, that hasnt offered much protection. In August 2020 police raided the premises and seized about $200,000 worth of cash and drugs. Pastor David Hodges told me he planned to sue the city government for violating his congregants religious freedom.
Potentially breaking the law was not my only concern when it came to trying magic mushrooms. I was an unusually suggestible child in the 1960s, when well-meaning parents scared their kids straight with stories about acid trippers who went blind from staring at the sun, mistook a baby for a turkey and stuffed it in the oven, or woke up convinced theyd turned into a glass of orange juice. In the late 1970s, when many of my college pals were experimenting, I declined even to smoke weed.
But last February, I was standing in front of the church out of desperation, hoping that psilocybin, the active ingredient in mushrooms, would relieve my excruciating pain. I was in my 12th week of a siege of cluster headaches, and I felt as if a Lilliputian with a tiny ice pick were jabbing at the back of my right eye for an hour each day, starting at 5 a.m.
Cluster headache is a rare disorder, estimated to affect roughly one or two in 1,000 people (migraines are at least 120 times as common). Theyd plagued me for a month or so every two years since 2005, and usually prednisone knocked them out. But this time the only thing that brought even brief respite wasno jokesnorting cayenne pepper, which made me sneeze until I felt as if I might pass out. I also worried that it might be corroding the inside of my nose.
Im far from the only person seeking out these long-demonized drugs for medical reasons. Using LSD, psilocybin, and MDMA (Ecstasy) to relieve suffering appears to be on the rise. While most self-experimenters use psychedelics to enhance well-being, a portion self-medicate preexisting mental health conditions, wrote psychiatrist Adam Winstock, M.D., in the Global Drug Survey. His annual polls of more than 500,000 people suggest that the use of LSD and psilocybin among respondents has roughly doubled over just the past five years. An honorary clinical professor at the Institute of Epidemiology at the University College of London, Dr. Winstock joins other experts in comparing the drugs favorably with prescription antidepressants. The benefits are really clear for patients, he says. They want things that work, work quickly, and dont require them to take medications every day.
If youve ever had cluster headaches, you know why theyve been called suicide headaches.
Americans interest in hallucinogens was supercharged by Michael Pollans 2018 best seller, How to Change Your Mind. A year later, Johns Hopkins launched a $17 million center to study a variety of illicit-drug therapies that showed promise in treating disorders such as depression, trauma, anorexia nervosa, tobacco addiction, and even post-treatment Lyme disease. Researchers are excited, even as psilocybin and LSD continue to be classified as Schedule I substances, which are seen as having no medical use, a high potential for abuse, and unacceptable risks even under professional supervision.
But if youve ever had cluster headaches, you know why theyve been called suicide headaches. People in the midst of an attack are believed to die by suicide at roughly three times the rate of the general population, and sufferers describe the attacks as more painful than childbirth, gunshot wounds, and kidney stones, according to University of West Georgia psychology professor Larry Schor, Ph.D., who has conducted a large survey of cluster-headache patients (and suffers from them himself). On average, cluster-headache patients take more than five years to be properly diagnosed, after which even prescribed drugs may fail. Early on, I tried taking sumatriptan, a drug for migraine headaches, and at first it was helpful, but then made my headaches worse, sending me to an emergency room three times. As this latest attack stretched on, I knew I had to try something new.
Researchers first investigated the potential therapeutic benefits of psychedelic drugs in the 1950s and 1960s, when hundreds of Americans, including actors Cary Grant, Rita Moreno, and Jack Nicholson, joined a series of supervised experiments in California. (Grant credited acid with helping him control his alcohol use and cope with the long-unexplained disappearance of his mother when he was a child.) The backlash began after Harvard lecturer Timothy Leary and psychologist Richard Alpert (who became known as Ram Dass) championed wider use of LSD and psilocybin, with Learys call to turn on, tune in, drop out becoming a slogan of the counterculture. President Richard Nixon branded Leary the most dangerous man in America and in 1971 launched the war on drugs.
These days, the hope is that psychedelics may help the many millions of Americans who suffer from depression and other serious mental disorders, particularly when nothing else has worked. The National Institute of Mental Health estimates that 17.3 million U.S. adults have at least one major depressive episode each year, while up to 30% dont receive sufficient help from mainstream anti-depressants. PTSD affects nearly 8 million people, including more than half a million U.S. veterans, while 40 million adults have anxiety. (Some of these rates were higher during the pandemic.) Researchers have been studying psychedelics to alleviate cluster headaches since 2006, but I learned of them through an activist patients group called Clusterbusters, which has touted their use since 2002.
Amid all the hoopla, some people may get a boost from just the idea of psychedelics: More than 60% of participants in a 2020 study said theyd experienced mind-altering effects after taking a placebo. Still, researchers have gathered sufficient evidence of psilocybins power to convince the FDA in 2019 to classify it as a breakthrough therapy for two types of severe depression. That fast-tracked it for approval, similarly to how esketamine (related to ketamine, an illegal party drug) was OKd for treatment-resistant depression that same year.
The treatment of PTSD may be the next potential boon: Some scientists have found MDMA both safer and more effective in treating trauma than conventional antidepressants. In May, a major study published in Nature Medicine provided new evidence along these lines, and late last year Rick Doblin, executive director of the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS), predicted that MDMA-assisted psycho-therapy for PTSD could win federal approval as soon as next year.
Its not clear just how psychedelics might supply mental and emotional benefitsor, in my case, relieve physical painbut scientists have some ideas. Studies suggest that psilocybin and other psychedelic drugs affect levels of serotonin, a neurotransmitter and hormone involved in regulating mood. MDMA is believed to activate receptors for oxytocin, a peptide linked to trust and bonding, possibly helping soften trauma sufferers defensive shells. So far the explosion of discoveries has involved small studies that need to be expanded and replicated. Yet the drumbeat of positive developments has likely helped increase official tolerance in some parts of the nation.
Many jurisdictions are considering rewriting their laws on psychedelics. In May 2019, Denver became the first U.S. city to decriminalize psilocybin mushrooms, and Oakland, CA, followed suit. Voters in Oregon and Washington, DC, have approved the therapeutic use of psilocybin, while California lawmakers recently took up a bill to decriminalize some hallucinogens. The trend is familiar: Whereas barely 20 years ago cannabis was outlawed everywhere in the United States, today 36 states and four territories have legalized it for medicinal purposes. (Decriminalization doesnt make a drug legal. It simply reduces penalties associated with it. Selling psychedelics is still illegal everywhere, and possession of them can lead to federal prosecution that could result in up to a year in prison and $1,000 or more in fines.)
Of course, breaking the law isnt the only risk involved. Some recreational magic mushroom users have reported frightening bad trips, panic attacks, seizures, and hospitalizations. Scientists and drug aficionados alike warn against casual use, and participants in psychedelic studies to date have all been carefully screened and supervised, with researchers rigorously excluding subjects with preexisting conditions such as heart trouble, schizophrenia, and bipolar disorder. I really worry about people in a time of crisis choosing to take psychedelics without supervision and making themselves worse, says Dr. Winstock, whose surveys indicate that approximately 8% of LSD and psilocybin users had a bad experience over the past year.
Still, in reporting a story for the Washington Post, I learned that many scientists regard psilocybin as one of the least toxic and addictive of all recreational drugs, and that the reports of bad trips involved much larger doses than the therapeutic amount for my cluster headaches. In severe pain, I decided to give it a try.
Psilocybins chemical structure is similar to melatonins, says Yale University neurologist Emanuelle Schindler, M.D., Ph.D., referring to a hormone that regulates circadian rhythm and is taken supplementally for insomnia as well as headache prevention. It is also akin to triptans, which are prescribed to treat one headache at a time. Psilocybin has a longer-term effect, though, notes Dr. Schindler, who is currently working on a study on its effects for cluster headaches.
Over the years, Clusterbusters members have offered invaluable support to Dr. Schindler and other scientists, recruiting patients for their studies and providing them with information from their self-treatment with psychedelics. In 2004, the group convinced Harvard researchers to conduct a pioneering study on psilocybin and LSD. The Harvard team gathered testimonies from 53 cluster-headache patients, most of whom said the drugs had helped. John Halpern, M.D., a psychiatrist who led the Harvard study, told me he has since seen many patients go from being incapacitated to having as close to a functional cure as you can get. The two drugs may prove to be the best we have to offer to cluster-headache patients, he adds, although legally we cant offer them.
The only psychedelic-ish effect that I noticed was that my dogs face was utterly gorgeous.
I followed Clusterbusters recommended protocol of taking small amounts of psilocybinmore than microdoses, but short of what would lead to trippingbrewed in a multi-ingredient tea containing lemon, honey, vitamin C, and a little instant coffee, with three doses spaced five days apart. The first time I didnt feel anything remarkable until the next morning, when I had a more-awful-than-usual headache: the slap-back side effect the website had warned me to expect. Over the next five days, however, I noticed that there were two days when I didnt have a headache at all.
Maybe a little overconfident, I overestimated with my second dose. Twenty minutes after sipping the tea, I found myself staring for half an hour at our backyard pistache tree, which seemed to have grown beckoning silvery branches. I felt as if I could see the tree breathing, which was wondrous. I was back to myself within a couple of hours, and the next morning I had another slap-back headache. But the two mornings after thatnothing. For the rest of the week, the headaches were milder.
Then I took my third dose, measuring carefully this time. The only psychedelic-ish effect that I noticedreally noticedwas that my dogs face was utterly gorgeous. Then I fell asleep next to my husband. I woke up to yet another fierce headache the next morning, but the morning after that I had zero pain. Zero again the next day, and the next. Two months have now passed without my having a single headache.
As the psychedelic-therapy revolution matures, there have been calls to ensure that its potentially powerful benefits are accessible to all. That will require some significant change considering that Black people are much more likely than white people like me to be arrested for possession of any drug, even after decriminalization.
Equity of access to these drugs will address the burden of disease we know is greatest among people of lower socio-economic status, who have higher rates of depression and PTSD, says Dr. Winstock. MAPS has trained scores of therapists of color to prepare for the time when treatment with them becomes legal.
In the meantime, research continues. It doesnt strike me as weird that the same molecule used by someone in a bedroom listening to Pink Floyd can also be a healing drug, says Dr. Winstock. He says that psychedelics capacity to disrupt existing brain networks and allow new pathways and new ways of thinking is why they can have wide potential in so many different conditions.
As for me, I cant say whether my cluster-headache siege ended on its own or whether using shrooms really did do the trick. But I do know that Ive got a plan if the headaches returnand that Ill never look at our pistache tree the same way again.
This article originally appeared in the August 2021 issue of Prevention.
This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at piano.io
Here is the original post:
'I Tried Psychedelics to Treat My Debilitating Cluster Headaches' - Prevention.com
- Review: Tripping on Utopia Complicates the History of Psychedelics - AOL - March 16th, 2024 [March 16th, 2024]
- Psychedelics Are Going Mainstream. Investing in Them Hasn't. - The Wall Street Journal - January 7th, 2024 [January 7th, 2024]
- Another Study Shows African Psychedelic Plant Ibogaine Treats Traumatic Brain Injury in Vets With 'Dramatic' Results - Good News Network - January 7th, 2024 [January 7th, 2024]
- Massachusetts Lawmakers Will Be Forced To Consider Psychedelics Legalization Measure That Activists Petitioned ... - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA to begin researching psychedelics as treatment option for veterans - Government Executive - January 5th, 2024 [January 5th, 2024]
- VA Is Funding New Research On Psychedelics' Benefits For Veterans With PTSD And Depression - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA ramps up study of psychedelic to treat PTSD - The American Legion - January 5th, 2024 [January 5th, 2024]
- Scientists predict DMT trip from cardiac activity - Big Think - January 5th, 2024 [January 5th, 2024]
- If psychedelics heal, how do they do it? | Proceedings of the National Academy of Sciences - pnas.org - January 5th, 2024 [January 5th, 2024]
- Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential | Molecular ... - Nature.com - January 5th, 2024 [January 5th, 2024]
- U.S. Rep. Correa supports using psychedelics to treat veterans with PTSD - New Santa Ana - January 5th, 2024 [January 5th, 2024]
- DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Psychedelics for Psych Conditions Made Their Mark in 2023 - Medpage Today - January 5th, 2024 [January 5th, 2024]
- 2023: A Good Trip Around the Sun for Psychedelics - The National Law Review - January 5th, 2024 [January 5th, 2024]
- Understanding the Role of the FDA in Advancing Psychedelic Therapy - Medriva - January 5th, 2024 [January 5th, 2024]
- MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics - Psychedelic Alpha - January 5th, 2024 [January 5th, 2024]
- Closing the innovation gap: Advancing psychedelic therapy and medicines in EU mental health care - Open Access Government - January 5th, 2024 [January 5th, 2024]
- The Austin Chronic: SXSW Is High on Psychedelics, as Cannabis Programming Wanes - Austin Chronicle - January 5th, 2024 [January 5th, 2024]
- This Forgotten Psychedelic Could Revolutionize Traumatic Brain Injury Treatment - Inverse - January 5th, 2024 [January 5th, 2024]
- A 'milestone' for psychedelics: Pentagon directed to study alternative treatments for veterans - Washington Times - January 5th, 2024 [January 5th, 2024]
- Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here's What's Next - Singularity Hub - January 5th, 2024 [January 5th, 2024]
- The top 8 psychedelic books you need to read | GreenState - GreenState - January 5th, 2024 [January 5th, 2024]
- Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC - Green Market Report - January 5th, 2024 [January 5th, 2024]
- DEA Calls For Even More THC, Psilocybin And DMT To Be Produced For Research In 2024 - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Here's What You Missed in Cannabis, Psychedelics This Week - TipRanks.com - TipRanks - January 5th, 2024 [January 5th, 2024]
- You're not tripping: State and local leaders give psychedelics another chance - Route Fifty - December 22nd, 2023 [December 22nd, 2023]
- Are Consciousness-Expanding Psychedelics Like Psilocybin More Effective Than Prozac, Zoloft, Xanax, and Other ... - Nautilus - December 22nd, 2023 [December 22nd, 2023]
- RFK, Ramaswamy And Williamson Push Psychedelics Reform On Presidential Campaign Trail - Marijuana Moment - December 22nd, 2023 [December 22nd, 2023]
- Peyote is the darling of the psychedelics renaissance. Indigenous users say it co-opts a sacred way of life - The Guardian US - December 22nd, 2023 [December 22nd, 2023]
- USask researchers explore untold history of psychedelics - News - University of Saskatchewan - USask News - December 22nd, 2023 [December 22nd, 2023]
- California Governor Says Psychedelics Have 'Profound' Healing Potential, But He's Undecided On Legalization Bill As ... - Marijuana Moment - September 25th, 2023 [September 25th, 2023]
- As psychedelic-assisted therapy grows, so does interest from a new group: chaplains - NPR - September 25th, 2023 [September 25th, 2023]
- This Maine City Moves Unanimously On Decriminalizing Psychedelics: Focus On Public Health - Benzinga - September 25th, 2023 [September 25th, 2023]
- Tech Leaders Are Finding Balance Through Microdosing Psychedelics - The Dales Report - September 25th, 2023 [September 25th, 2023]
- Chronic Pain Can Be Treated by Psychedelics, Survey Suggests - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Insights Into the First Psychedelic-Assisted Therapy Guidelines With ... - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Living with long-term cancer is depressing. Texas doctors say psychedelics could help - The Hill - July 19th, 2023 [July 19th, 2023]
- Couples Are Doing MDMA and Ketamine Therapy To Save Their Relationships - VICE - July 19th, 2023 [July 19th, 2023]
- The Way People Are Using Psychedelics Is Changing Amid Reform ... - Marijuana Moment - July 19th, 2023 [July 19th, 2023]
- [WATCH] Turn on, tune in, legalise: Could psychedelics be next in ... - MaltaToday - July 19th, 2023 [July 19th, 2023]
- Will Psychedelics Be Rescheduled After FDA Approval? - Harris Bricken - July 19th, 2023 [July 19th, 2023]
- The Psychedelic Preparedness Scale: A Tool to Optimize Trip ... - Filter - July 19th, 2023 [July 19th, 2023]
- How to Test Psychedelics for Adulterants with Testing Kits - Psychedelic Spotlight - July 19th, 2023 [July 19th, 2023]
- Cannabis Science Conference to debut in Providence, R.I., with ... - GlobeNewswire - July 19th, 2023 [July 19th, 2023]
- New Speaker Rivas weighs in on psychedelics, housing and health care worker minimum wage - Yahoo News - July 19th, 2023 [July 19th, 2023]
- TDR's Top 5 Psychedelic Developments For The Week Of July 10 - The Dales Report - July 19th, 2023 [July 19th, 2023]
- Psychedelic Treatment with Psilocybin Relieves Major Depression, Study ... - February 20th, 2023 [February 20th, 2023]
- Johns Hopkins Launches Center For Psychedelic Research - February 20th, 2023 [February 20th, 2023]
- Psilocybin Treatment for Major Depression Effective for Up to a Year ... - February 20th, 2023 [February 20th, 2023]
- Inside the Johns Hopkins Psilocybin Playlist - Hopkins Medicine - February 20th, 2023 [February 20th, 2023]
- Research Story Tip: Psychedelic Drug Psilocybin Tamps Down Brains Ego ... - February 20th, 2023 [February 20th, 2023]
- Psychedelics: Risks, benefits, and more - Medical News Today - February 18th, 2023 [February 18th, 2023]
- Psychedelic Drug Effects, Side Effects & Dangers - January 25th, 2023 [January 25th, 2023]
- Psychedelics Decriminalization Project In Berkeley, Cal Includes ... - January 6th, 2023 [January 6th, 2023]
- Ancient mummified child was drugged with psychedelics before ritual ... - December 14th, 2022 [December 14th, 2022]
- The therapeutic potential of psychedelics - Science - December 14th, 2022 [December 14th, 2022]
- Changing Lives with Psychedelics: How Connecticut researchers are using magic mushrooms to help people overcome depression, OCD - WTNH.com - November 19th, 2022 [November 19th, 2022]
- Penis Envy Mushroom | Legal Psychedelics | Magic Mushroom - November 7th, 2022 [November 7th, 2022]
- Psychedelics. Discussing natural and synthetic friends. Science, News ... - November 5th, 2022 [November 5th, 2022]
- The Harms of Psychedelics Need to Be Put Into Context - WIRED - November 5th, 2022 [November 5th, 2022]
- Packers' Aaron Rodgers says psychedelics led to his back-to-back MVP ... - October 28th, 2022 [October 28th, 2022]
- With Promise of Legalization, Psychedelic Companies Joust Over Future Profits - The New York Times - October 25th, 2022 [October 25th, 2022]
- How do psychedelics work? This brain region may explain their effects - PBS - October 21st, 2022 [October 21st, 2022]
- Why is the American right suddenly so interested in psychedelic drugs? - The Guardian - October 19th, 2022 [October 19th, 2022]
- Can Psychedelics Cure? Science Is on the Verge of Finding Out - Newsweek - October 19th, 2022 [October 19th, 2022]
- Large national survey suggests that the use of psychedelics is not associated with lifetime cancer development - PsyPost - October 19th, 2022 [October 19th, 2022]
- This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More - Small Pharma - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Made the Mushrooms Magic: Psychedelic Study Explores the Odd Evolution of Mind-Altering Fungi - The Debrief - October 19th, 2022 [October 19th, 2022]
- Psychedelics And Wellness: The Healing Company Buys PepsiCo-Backed Superfoods Company - (HLCO) - Benzinga - October 19th, 2022 [October 19th, 2022]
- What's on the Colorado ballot? Housing, psychedelics, school meals, alcohol, taxes and more | FOX31 Denver - FOX 31 Denver - October 19th, 2022 [October 19th, 2022]
- DoseConnect to Sponsor the Tech Stage at Wonderland Miami by Microdose - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Is Going on With Bright Minds (DRUG) Stock Today? - InvestorPlace - October 19th, 2022 [October 19th, 2022]
- Psychedelics May Ease Fear of Death and Dying - October 17th, 2022 [October 17th, 2022]
- TDR's Top 5 Psychedelic Developments For The Week Of October 10 - The Dales Report - October 17th, 2022 [October 17th, 2022]
- DEA Wants To Boost Production Of Cannabis & Psychedelics For Research In 2023 - Benzinga - October 17th, 2022 [October 17th, 2022]
- Talk set to explore psychedelics and mental health - Reading Today - October 17th, 2022 [October 17th, 2022]
- Silo Wellness Closes Acquisition of Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- How does psilocybin rewire the brain? - Open Access Government - October 17th, 2022 [October 17th, 2022]
- HYTN Awarded Controlled Drugs and Substances Dealers License Allowing for Production and Sale of Psilocybin - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- The Healing Company acquires leading superfoods business, Your Super, and lands $150M credit facility to expand community of brands - Yahoo Finance - October 17th, 2022 [October 17th, 2022]